Page last updated: 2024-10-29

indomethacin and Secondary Hyperparathyroidism

indomethacin has been researched along with Secondary Hyperparathyroidism in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lozance, LA1
Zafirovska, KG1
Bogdanovska, SV1
Zafirovski, GJ1

Other Studies

1 other study available for indomethacin and Secondary Hyperparathyroidism

ArticleYear
Primary disseminated form of Ewing sarcoma in association with hypercalcemia and acute renal failure.
    Renal failure, 1994, Volume: 16, Issue:4

    Topics: Acute Kidney Injury; Adult; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism,

1994